01 Mai 2026

INSIGHT 2026: Meet More Experts

INSIGHT 2026 continues its series of speaker spotlights, with a closer introduction to three more confirmed experts who will contribute their knowledge and experience to this year's edition of the pharmaceutical conference in Dublin.

Prof. Matthias G. Wacker
Matthias Wacker is a Professor of Biopharmaceutics and Pharmaceutical Technology with a strong focus on biopredictive in vitro testing, IVIVC, and computational modeling. His work aims to bridge the gap between formulation development and in vivo performance. At INSIGHT 2026, he will address innovative release testing strategies for complex and parenteral drug products.

Nathan Schulpen, M.Sc.
With more than ten years of experience in dissolution sciences, Nathan Schulpen brings a clear industry perspective to the conference. Working at Johnson & Johnson, he has been deeply involved in dissolution method development and the global implementation of automated testing solutions. His session will focus on transferring automated approaches from R&D into commercial manufacturing environments.

Prof. Eric Beyssac, Ph.D.
Eric Beyssac is Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Clermont Auvergne. His expertise includes dissolution testing, IVIVC, and sustained-release formulations. At INSIGHT 2026, he will lead a practical workshop on complex dosage forms and flow-through cell techniques, combining scientific fundamentals with hands-on application.

This spotlight offers just a brief introduction – full speaker profiles and session details can be found on insight2026.com.